🔩 SIERRA PACIFIC ENGINEERING & PRODUCTS (HQ: United States) manufactures and supplies industrial access hardware such as latches, hinges and handles to OEM manufacturers and distributors. Their advanced manufacturing technology, innovative designs and expertise are recognized globally. Sierra Pacific Engineering & Products plans on expanding throughout the United States. Learn more about the Sierra Pacific Engineering & Products project here.

👩‍💻 LOGI-SERVE (HQ: United States) offers talent assessment solutions that identify, predict and develop skills. Their system analyzes candidate response data using algorithms that generate scores that predict the fit and performance outcomes directly tied to financial impact. Logi-Serve also offers an interactive Realistic Job Preview (iRJP) tool that can be partnered with the assessments or used separately to educate and engage potential candidates. Logic-Serve plans on expanding into Japan. Learn more about the Logi-Serve project here.

💧 STREAMLINE INNOVATIONS (HQ: United States) is a cleantech company that deploys solutions for water and gas treatment and other related processes within the oil, gas, utilities and industrial markets. Their solutions enable their customers to transition into more sustainable operations by treating natural gas and water with specialized capabilities in addressing H2S, CO2 and other contaminants. Streamline Innovations is looking to expand into Canada. Learn more about the Streamline Innovations project here.

♻️ TECNARO GMBH (HQ: Germany) develops and sells biodegradable materials. Their key products include Liquid Wood Arboform, Wood Plastic Composites Arbofill, and Biopolymer Compound Arboblend. The company’s customers are active in the packaging, stationery, furniture, fashion, automotive, and solar industries. Tecnaro GMBH is looking to expand throughout Germany. Learn more about the Tecnaro GMBH project here.

🧪 CENTRE FOR COMMERCIALIZATION OF REGENERATIVE MEDICINE (HQ: Canada) is a not-for-profit, public-private organization that supports partners, start-ups and small firms in the development and commercialization of cell and gene therapies and regenerative medicine (RM) technologies. The Centre for Commercialization of Regenerative Medicine (CCRM) aims to fill the gap between the laboratory and the stage where RM-based treatments can be used in medicine and reach patients. The Centre for Commercialization of Regenerative Medicine is looking to expand into the United States. Learn more about the Centre for Commercialization of Regenerative Medicine project here.